NCCR-Synapsy

The Synaptic Bases of Mental Diseases

Gliapharm completes a CHF 2 Million financing to advance its drug development program

GliaPharm SA has completed a CHF 2 million financing. The company is initially focusing on an orphan neurological disease caused by a deficiency in brain metabolism that affects more than 100’000 children around the world from an early age through Read more…


Optimus Agora Prize for Carmen Sandi and Dominique de Quervain

Dominique de Quervain and Carmen Sandi are being awarded Optimus Agora Prize. Their project “Stress” encourages interaction with the public. Stress is part of everyday life. Better understanding it, and knowing how to prevent situations that cause it, improves our Read more…